# Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer

> **NCT04453904** · NA · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 654 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **OTHER:** sequential radiochemotherapy in a "sanwich" mode

## Key facts

- **NCT ID:** NCT04453904
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-12
- **Primary completion:** 2025-04
- **Final completion:** 2027-04
- **Target enrollment:** 654 (ESTIMATED)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453904, "Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04453904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*